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Abstract
Changes in epigenetic programming of embryonic growth genes during pregnancy seem to affect fetal growth. Therefore,
in a population-based prospective birth cohort in the Netherlands, we examined associations between fetal and infant
growth and DNA methylation of IGF2DMR, H19 and MTHFR. For this study, we selected 69 case children born small-for-
gestational age (SGA, birth weight ,-2SDS) and 471 control children. Fetal growth was assessed with serial ultrasound
measurements. Information on birth outcomes was retrieved from medical records. Infant weight was assessed at three and
six months. Methylation was assessed in DNA extracted from umbilical cord white blood cells. Analyses were performed
using linear mixed models with DNA methylation as dependent variable. The DNA methylation levels of IGF2DMR and H19 in
the control group were, median (90% range), 53.6% (44.5–61.6) and 30.0% (25.6–34.2) and in the SGA group 52.0% (43.9–
60.9) and 30.5% (23.9–32.9), respectively. The MTHFR region was found to be hypomethylated with limited variability in the
control and SGA group, 2.5% (1.4–4.0) and 2.4% (1.5–3.8), respectively. SGA was associated with lower IGF2DMR DNA
methylation (b=21.07, 95% CI21.93;20.21, P-value = 0.015), but not with H19 methylation. A weight gain in the first three
months after birth was associated with lower IGF2DMR DNA methylation (b=20.53, 95% CI 20.91; 20.16, P-value = 0.005).
Genetic variants in the IGF2/H19 locus were associated with IGF2DMR DNA methylation (P-value,0.05), but not with H19
methylation. Furthermore, our results suggest a possibility of mediation of DNA methylation in the association between the
genetic variants and SGA. To conclude, IGF2DMR and H19 DNA methylation is associated with fetal and infant growth.
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Introduction
One of the main causes of perinatal morbidity and mortality is
being born small-for-gestational age (SGA) [1,2]. SGA can be the
result of a poor prenatal environment, which could have been
induced by an adaptive response during fetal life [3]. These infants
are particular at risk for early onset of non-communicable diseases
when they also experience a period of catch up growth during the
first months of life [4]. One of the proposed underlying
mechanisms are changes in epigenetic markings acquired and
maintained during pregnancy, which are not directly related to the
DNA sequence itself [5].
One of the best understood epigenetic mechanisms are
modifications in DNA methylation which occur predominantly
at cytosines of CpG dinucleotides [5]. To establish and maintain
DNA methylation patterns, methyl donors, such as folate and
choline, acting as intermediates in the one-carbon pathway are
required [6]. Low intake of methyl donors and subtle genetic
variations in methyltetrahydrofolate reductase (MTHFR) can
derange the one carbon pathway resulting in a mild to moderate
hyperhomocysteinemia. Associations have been reported between
elevated maternal homocysteine levels during pregnancy and a
lower birth weight and increased risk of SGA [7]. Moreover,
hyperhomocysteinemia also affects DNA methylation levels [8,9].
Although DNA methylation patterns are believed to be
relatively stable, it seems that exposures, particularly during the
prenatal period, can permanently alter DNA methylation patterns
in offspring [10]. Especially genes that are expressed in a parent-
of-origin-specific manner, known as imprinted genes, are of
interest as they are essential during development and regulated
through epigenetic mechanisms [11]. The IGF2/H19 imprinted
region is one of the best studied loci. In humans, exposure to
famine during the periconceptional period has been linked to
altered DNA methylation patterns of the insulin-like growth factor
2 (IGF2DMR) in adulthood [12]. Also, periconceptional folic acid
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supplement use is associated with increased methylation of the
IGF2DMR in humans and IGF2DMR methylation was inversely
associated with birth weight [13].
We hypothesized that changes in fetal growth and subsequent
early infant growth are partly due to alterations in DNA
methylation of genes implicated in fetal and infant growth.
Therefore, we assessed DNA methylation in 2 imprinted genes
(IGF2 and H19) and 1 non imprinted folate gene (MTHFR). Our
main focus was to investigate the association between SGA and
DNA methylation. Next, we examined associations between fetal
and infant growth and DNA methylation. In addition, we
investigated whether genetic variations within the investigated
genes are associated with DNA methylation. Furthermore, we
explored the possible mediation of DNA methylation in the
association between the genetic variants and SGA.
Materials and Methods
Design and study population
This study was embedded in the Generation R study, a
population-based cohort study from early fetal life onwards in
Rotterdam, the Netherlands [14]. The study has been approved
by the Medical Ethical Committee of the Erasmus Medical Center
in Rotterdam (MEC 198.782/2001/31). Written consent was
obtained from all participating mothers for both maternal and
child data. Mothers were enrolled during pregnancy, between
2001 and 2005. In total, 8880 mothers were enrolled during
pregnancy.
The present study was carried out in a subset of the original
Generation R cohort (n = 540). Analyses were restricted to Dutch
singleton pregnancies (n = 4,829) and infants with available DNA
extracted from umbilical cord white blood cells (n = 3,127). From
this study group all infants born with a gestational-age and sex-
adjusted birth weight below 22 standard deviation score (SDS)
(n = 69) were selected for analysis. The current study is part of a
project, in which we investigate the hypothesis that both SGA and
children with attention deficit hyperactivity disorder (ADHD) have
a shared causality in DNA methylation of especially imprinted
fetal growth genes. Therefore, 92 children were included with
ADHD based on parent interview Diagnostic Inventory of
Screening Children or Child Behavior Checklist teacher report
at age 6. Two of the infants with ADHD were also born with a
gestational-age and sex-adjusted birth weight below 22 SDS. The
remaining 381 control infants were randomly selected. Therefore,
the control group consisted of 90 ADHD children and 381 infants
who were randomly drawn.
Fetal and infant growth
Fetal ultrasound measurements were performed to assess
gestational age and to estimate fetal growth [15]. Crown-to-rump
length was used for pregnancy dating until a gestational age of 12
weeks and 5 days (crown-to-rump length,65 mm), and biparietal
diameter (BPD) for pregnancy dating thereafter (gestational age
from 12 weeks and 5 days onwards, BPD. 23 mm). Fetal growth
characteristics included head circumference, BPD, abdominal
circumference, and femur length and were measured trans-
abdominal to the nearest millimeter using standardized ultrasound
procedures in mid pregnancy (median 20.5 weeks of gestation,
90% range 19.1–22.4) and late pregnancy (median 30.4 weeks of
gestation, 90% range 28.8–32.1). Estimated fetal weight (EFW)
was calculated using the formula by Hadlock [16]. A gestational
age-adjusted SDS, based on reference growth curves from the
entire study population, was constructed for EFW [15].
Information concerning date of birth, infant sex and birth
weight was obtained from the medical records of community
midwives and hospitals [14]. Gestational age and sex-adjusted
SDS were constructed for birth weight, according to the
methodology of Niklasson et al [17]. SGA was defined according
to the International SGA Advisory Board Panel as a gestational
age and sex-adjusted birth weight below 22 SDS [18]. Born
appropriate for gestational age (AGA) was defined as a gestational
age and sex-adjusted birth weight $22 SDS. Born large for
gestational age (LGA) was defined as a gestational age and sex-
adjusted birth weight$2 SDS. The growth rate of weight between
mid-pregnancy and birth was calculated as (birth weight SDS -
EFW SDS in mid pregnancy).
Trained staff in community health centers obtained information
on infant weight during periodic visits scheduled at three (median
3.3 months, 90% range 3.0–3.9) and six months (median 6.2
months, 90% range 5.5–7.4) [14]. For every visit, an age- and sex-
adjusted SDS for weight was calculated with the use of Dutch
reference curves (Growth Analyzer 3.0, Dutch Growth Research
Foundation, Rotterdam, the Netherlands). Infant growth rates of
weight gain in the first three and six months after birth were
calculated as (weight at three or six months SDS – birth weight
SDS).
Assessment of DNA methylation and genotyping
Genomic DNA was isolated from umbilical cord white blood
samples at birth as previously been described [19]. Based on
previous studies, three loci were selected for the assessment of
DNA methylation [9,20]. DNA methylation of IGF2DMR and
H19 have been previously studied by other groups [12,20].
However, DNA methylationMTHFR has not been studied before.
It was chosen as it is a key enzyme in the one carbon pathway. A
CpG island outside the MTHFR gene was selected for analyses.
Primers were designed using the online tool of MySequenom.com.
Details of the measured amplicons can be found in Table S1.
Isolated genomic DNA (500 ng) was treated with sodium
bisulphite for 16 hours using the EZ-96 DNA methylation kit
(Shallow) (Zymo Research, Irvine, CA, USA), according to the
manufactures’ protocol. Samples were randomly distributed on six
96-well plates. The bisulphite treatment was followed by PCR
amplification, fragmentation after reverse transcription and
analysis on a mass spectrometer, according to the manufactures’
protocol (Sequenom, Inc, San Diego, USA). This generated mass
signal patterns that were translated into quantitative DNA
methylation levels of different CpG sites of the selected genes by
MassARRAY EpiTYPER Analyzer software (v1.0, built 1.0.6.88
Sequenom, Inc, San Diego, USA) [21,22]. Fragments containing
one or more CpG sites were called CpG units. PCR and
subsequent steps were done in triplicate.
Data quality control for methylation consisted of exclusion of
CpG units with too low or too high mass or CpG units with
overlapping or duplicate RNA fragments (e.g. silent signals) were
excluded from further analysis. Furthermore, at least two out of
three of the replicate measurements per CpG unit had to be
successful, the standard deviation of the duplicates or triplicates
had to be #0.10 and the success rate per CpG unit had to be
$75%. Last, CpG units that contained a known SNPs with a
frequency .5% were also excluded, as this could change the
weight of the CpG unit and therefore interfere with the
measurement. Details concerning the success rate of the amplicons
can be found in Table S2.
Based on literature [23], four SNPs in the IGF2/H19 locus were
identified that were associated with birth weight in Caucasian
children. Subsequently, two genetic variants of the MTHFR gene
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which have been associated with global DNA methylation were
identified [24]. Genotypes were obtained using high-density SNP
arrays (Illumina) and then imputed for ,2.4 million HapMap
SNPs (Phase II, release 21/22). Frequency distribution conformed
to the Hardy-Weinberg equilibrium. Details concerning the SNPs
can be found in Table S3.
Covariates
From self-administered questionnaires, data was available on
maternal age and maternal educational level, parity, smoking and
folic acid supplement use before and during pregnancy. Maternal
education level was assessed by the highest completed education
and classified as 1) none/primary or ‘low’; 2) secondary or
‘medium’; 3) college/university or ‘high’. Parity was classified as
(1) nulliparous and (2) multiparous. Maternal smoking was assessed
in each trimester. Women, who reported any or no smoking
during pregnancy were respectively classified as ‘smokers’ and
‘non-smokers’. Folic acid supplement use was categorized into 1)
folic acid supplement use (pre- or postconceptional start); 2) no
folic acid supplement use. At enrolment (median 13.5 weeks, 90%
range 10.7; 21.6) maternal weight and height were measured to
calculate body mass index (BMI, kg/m2). From hospital medical
records, the occurrence of hypertension and hypertension-related
pregnancy disorders were obtained [25]. Preeclampsia was defined
according to the criteria described by the International Society for
the Study of Hypertension in Pregnancy (ISSHP) [26].
Statistical analysis
First, we tested for differences in maternal or infant character-
istics between cases and controls using chi-square, Mann-Whitney
U and T-tests. Second, linear mixed models were used to examine
the associations between fetal or infant growth (independent
variable) and DNA methylation (dependent variable). This model
was chosen as it can account for correlation between CpG
dinucleotides, incorporates relevant adjustments within the models
and has the ability to accommodate missing data. The restricted
maximum likelihood (REML) method was used for the model
fitting. DNA methylation was treated as a continuous variable. To
achieve normality, DNA methylation was square root trans-
formed. Outliers per CpG (.3SD) were excluded from further
analysis. For all analyses, subject/person identifier was added as
random effect and bisulphite batch and CpG site were added as
fixed effects. In the crude analyses, the growth characteristic was
entered as a fixed effect. Potential confounders were additionally
entered to the model at the same time as fixed effects. In addition,
the analyses were also repeated with exclusion of the ADHD and
the LGA cases. Third, associations between genetic variants in the
IGF2/H19 locus and the MTHFR gene and DNA methylation
levels (dependent variable) were investigated using a linear mixed
model. The genotype was entered to the model continuously as a
fixed effect. Subsequently, we explored the possibility of mediation
of DNA methylation in the association between the genetic variant
and SGA using logistic regression models.
Missing data of maternal educational level (1.3%), folic acid
supplement use (18.5%) and smoking (6.3%) were completed using
the Markov-Chain-Monte-Carlo multiple imputation technique
[27]. Ten imputed datasets were created. For all analyses, results
including imputed missing data are presented. Multiple testing
correction was performed according to the method developed by
Bonferroni. The linear mixed model analyses were performed
using the data measured in triplicates. All analyses were performed
using the Statistical Package of Social Sciences version 20.0 for
Windows (SPSS Inc, Chicago, IL, USA).
Results
The maternal and fetal characteristics are presented in table 1.
Mothers of children born SGA were lower educated, more often
nulliparous, smoked more often during pregnancy, used less often
a folic acid supplement during the periconceptional period and
more frequently developed preeclampsia (all P-value,0.05). The
median (90% range) DNA methylation levels of IGF2DMR, H19
and MTHFR were 53.2% (44.3–61.3), 30.1% (25.5–34.2) and
2.5% (1.4–4.0) respectively. The median (90% range) DNA
methylation levels of IGF2DMR, H19 and MTHFR in the AGA
group were 53.6 (44.5–61.6), 30.0 (25.6–34.2) and 2.5 (1.4–4.0),
respectively. The median (90% range) DNA methylation levels of
IGF2DMR, H19 and MTHFR in the SGA group were 52.0 (43.9–
60.9), 30.5 (23.9–32.9) and 2.4 (1.5–3.8), respectively. As the
MTHFR region was found to be hypomethylated with limited
variability, no further analyses were conducted within this region.
Table 2 shows the associations between the occurrence of SGA
(categorical) and DNA methylation levels of IGF2DMR and H19.
SGA was associated with lower IGF2DMR DNA methylation
(b=21.07, 95% CI 21.93; 20.21, P-value = 0.015). Expressed
relative to the standard deviation, this difference corresponds with
a standardized effect size in DNA methylation of20.13 SDS units.
No associations were observed between SGA and H19 methyla-
tion. After multiple testing adjustment (three independent loci), the
association of SGA with IGF2DMR methylation remained
significant.
Table 3 shows the associations between fetal and infant growth
and DNA methylation. As the SGA cases were oversampled in the
data, the analyses were performed in the total study population,
but were also stratified for SGA or AGA. In the total study
population, lower IGF2DMR DNA methylation was associated
with an increase in weight in the first three months after birth
(b=20.46, 95% CI 20.86; 20.07, P-value = 0.022), correspond-
ing to a standardized difference in DNA methylation of 20.06
SDS. In the total study population, no association was found with
H19 methylation. After the analyses were stratified for SGA and
AGA, higher H19 methylation was associated with an increase in
weight in the first three months after birth (b=0.35, 95% CI 0.03;
0.68, P-value = 0.034) in children born AGA, which corresponds
with a standardized difference in DNA methylation of20.05 SDS.
Table 4 shows the associations between genetic variants in the
IGF2/H19 locus and DNA methylation. Genetic variants in the
IGF2/H19 locus were associated with both higher (rs3741205,
rs2251375) and lower (rs2067051) DNA methylation of IGF2DMR
(rs3741205, C-allele: b=1.20, 95%0.71; 1.69, P-val-
ue = 2.061026, rs2067051, C-allele: b=20.44, 95% CI 20.86;
20.02, P-value = 0.041 and rs2251375, A-allele: b=0.48, 95% CI
0.04; 0.93, P-value = 0.033), which corresponds to a standardized
difference in DNA methylation of 0.15 SDS (rs3741205), 0.06
SDS (rs2067051) and 0.06 SDS (rs2251375). The genetic variants
was not associated with H19 methylation. The IGF2 SNP
(rs3741205) showed a significant association with birth weight
(beta 127 grams, 95% CI 40; 215, p-value = 0.004), but the H19
SNPs did not (rs2067051: beta -35 grams,95% CI 2109; 39, p-
value = 0.349; rs2251375: beta 18 grams,95% CI 260; 97, p-
value = 0.643; rs4929984: beta -21 grams,95% CI -96; 53, p-
value = 0.572). Next, we explored the possibility of mediation of
DNA methylation in the association between the genetic variant
rs3741205 and SGA, which is depicted in table 5. The genetic
variant rs3741205 was chosen, because of its strong association
with IGF2DMR DNA methylation. The risk allele of the genetic
variant rs3741205 was significantly associated with an increased
risk of SGA (adjusted odds ratio (aOR) 1.41, 95% CI 1.24; 1.61,
DNA Methylation and Fetal and Infant Growth
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P-value = 1.961027). Afterwards, the mean DNA methylation of
IGF2DMR was added to the model and the effect was attenuated
(aOR 1.26, 95% CI 1.10; 1.44, P-value = 0.001).
Last, the analyses were repeated with the exclusion of the
ADHD cases and subsequently with the exclusion of LGA cases.
The results of the ADHD cases are depicted in Table S4. After
exclusion of the ADHD cases, the previous found associations
remained and the effect estimates did not change substantially.
The results of the LGA cases can be found in Table S5. After
exclusion of the LGA cases, the previous observed associations
remained and the effect estimates did not change substantially.
Discussion
In 540 children, derived from a population-based birth cohort,
we examined whether DNA methylation levels of the IGF2DMR,
H19 and MTHFR gene in cord blood were associated with fetal
and infant growth.
The IGF2 and H19 loci have been studied extensively in the past
and are strong candidate genes for influencing birth weight [23].
In our study, lower DNA methylation of IGF2DMR was observed
in children born SGA. There have been conflicting results
regarding the association between IGF2/H19 DNA methylation
and fetal and infant growth [28,29,30,31]. A recent study by St-
Pierre et al. [31] studied IGF2/H19 DNA methylation at both the
maternal and the fetal side of the placenta in relation to fetal birth
anthropometrics. In this study, higher IGF2DMR DNA methyla-
tion was associated with higher birth weight. Moreover, they
showed that alterations in IGF2/H19 DNA methylation are likely
to be functional, because of the established positive association
with circulating IGF2 concentrations in cord blood. In addition,
Table 1. Maternal and infant characteristics.
All infants n=540 Controls n=471 SGA n=69 P-value1
Maternal characteristics
Age at intake (years)* 30.3 (5.1) 30.3 (5.1) 30.0 (5.4) NS
Body mass index at intake (kg/m2){ 23.3 (19.3–32.4) 23.3 (19.4–32.4) 22.8 (18.9–30.9) NS
Education (%) 0.003
Primary education 4.4 3.8 8.7
Secondary education 45.9 45.9 46.4
Higher education 48.3 49.3 42.0
Missing 1.3 1.1 2.9
Parity (%) ,0.001
0 66.9 64.1 85.5
$1 33.1 35.9 14.5
Smoking status during pregnancy (%) 0.003
Yes 23.1 21.9 31.9
Until pregnancy recognition 8.7 8.5 10.1
No 61.9 63.3 52.2
Missing 6.3 6.4 5.8
Folic acid supplement use during pregnancy (%) ,0.001
Start preconception 43.5 45.2 31.9
Start postconception 25.9 24.8 33.3
No 12.0 11.5 15.9
Missing 18.5 18.5 18.8
Preeclampsia (%) 2.0 1.3 7.2 ,0.001
Infant characteristics
Gender (% boys) 57.8 57.3 60.9 NS
Estimated fetal weight (grams), mid-pregnancy{ 358.2 (257.7–537.4) 359.5 (364.3–544.7) 352.5 (238.1–502.4) ,0.001
Estimated fetal weight (grams), late-pregnancy{ 1538.2 (1199.1–2032.6) 1589.4 (1251.5–2038.2) 1362.9 (1118.6–1564.3) ,0.001
Gestational age at birth (weeks){ 40.3 (37.6–42.1) 40.3 (37.4–42.1) 40.3 (37.7–42.1) NS
Birth weight (grams){ 3418 (2491–4300) 3510 (2735–4325) 2625 (1930–2830) ,0.001
Weight (grams), 3 months{ 6215 (4990–7541) 6260 (5120–7613) 5690 (4823–6545) ,0.001
Weight (grams), 6 months{ 7690 (6320–9255) 7820 (6450–9330) 7085 (5890–9250) ,0.001
IGF2DMR methylation (%){ 53.2 (44.3–61.3) 53.6 (44.5–61.6) 52.0 (43.9–60.9) 0.003
H19 methylation (%){ 30.1 (25.5–34.2) 30.0 (25.6–34.2) 30.5 (23.9–32.9) NS
Values are presented as
*mean (standard deviation) and
{median (90% range).
1Student’s T-test, Mann Whitney U and chi-square tests are used to test differences between the control group and the SGA group.
doi:10.1371/journal.pone.0081731.t001
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Displas et al. reported loss of imprinting of IGF2/H19 in placentas
of children with intrauterine growth restriction [30]. In contrast to
our findings, Tobi et al. has found no association between
IGF2DMR methylation and SGA (difference SGA and AGA
20.2%)[29], which might be explained by their study population
of preterm born children (,32 weeks). and the use of a different
definition for SGA (,21 SDS) than ours (,22SDS). In contrast
to previous studies, we included postnatal growth parameters in
addition to birth outcomes and found an association between an
increase in weight as marker of postnatal growth in the first three
months after birth and IGF2DMR methylation. As it has been
shown that children born AGA and SGA have different postnatal
growth patterns, we have shown the postnatal analyses separately.
Postnatal growth acceleration has been previously identified as an
important risk factor for the development of diseases in later life
[32], which could partly be explained by epigenetic reprogram-
ming. In our study, the SGA group is nearly 7 fold smaller than
the AGA group. Therefore, a power problem seems a likely
explanation for not finding this association in the SGA group. It
would be interesting to address this question in future studies.
IGF2 methylation levels determined in umbilical cord white
blood cells were positively associated with birth weight [31,33].
Therefore, the association of SGA lower DNA methylation levels
of IGF2DMR seems to be in contrast to the concept that increased
methylation is associated with transcriptional silencing of the
associated gene [5], but is in line with the increase in weight in the
first three months after birth and lower IGF2DMR methylation
levels. Adverse exposures have been previously linked to a
decrease in methylation whereas advantageous exposures have
been associated with increased methylation [12,13]. Therefore,
DNA methylation can be regarded as a memory of previous
exposures and alterations could have consequences in subsequent
growth and development. St-Pierre et al [31] showed that 31% of
the variance of birth weight is explained by the IGF2/H19
epigenotype and a genetic variant (rs2107425), which is in linkage
disequilibrium (LD) with one of the SNPs that we have
investigated, namely rs2251375 (R-squared 1.000).
IGF2 and H19 are both imprinted genes and loss of imprinting
of the IGF2/H19 locus has been observed in the Beckwith-
Wiedemann syndrome, a congenital overgrowth disorder [34]. In
this study, a significant positive association was observed between
the polymorphism rs3741205 and IGF2DMR methylation. This
genetic variant is a defining SNP of a CAGA haplotype in the
IGF2 DMR0 region which has been previously described in
patients with a sporadic form of Beckwith-Wiedemann syndrome
[35] and the presence of the C-allele has also been positively
associated with birth weight [23]. Recently, lower IGF2 DMR
methylation has been associated with the minor allele of the IGF2
SNP rs2239681, which is in LD with one of the SNPs that we have
investigated, namely rs3741205 (R-squared 0.912) [20]. In
addition, our results suggest the possibility of mediation of DNA
methylation in the association between the genetic variants and
SGA. These observations could provide evidence for the complex
interplay between the genome, epigenome and environmental
factors in growth disorders.
In this study, we found the MTHFR region in both groups to be
hypomethylated with limited variability. Therefore, no analyses
were performed within this region. With the current methods for
DNA methylation measurement, we do not recommend for others
to investigate this region z
Methodological considerations
Some strengths and limitations of this study have to be
addressed. This study was embedded in a large cohort from
whom a selection of Dutch children was studied. As the SGA cases
were oversampled in the data, the analyses were performed in all
infants and SGA and AGA. The study population also consisted of
92 children with ADHD and 11 children born LGA, which could
potentially influence our results. Therefore, all analyses were
repeated without the ADHD and LGA children. As this did not
change our results substantially, these children were not excluded.
This study showed modest changes in DNA methylation, which
remained after multiple testing correction. Our findings are in line
with the influences of periconceptional folic acid supplement use
and adverse intrauterine exposures, such as the Dutch famine
during 1944-45, showing modest epigenetic changes in early and
adult life [12,13]. A recent study by Talens et al [36] has
demonstrated that epigenetic changes accumulate over time, both
at imprinted (including IGF2DMR) and non-imprinted loci.
Unfortunately, we were not able to assess whether the DNA
methylation variations also result in changes in expression and
long-term functional effects. In addition, the issue remains whether
the measured DNA methylation differences reflect true methyla-
tion changes of the candidate genes of interest. The aim of this
study was to estimate differences in the quantitative DNA
methylation at selected individual CpG sites of candidate loci.
This seems particularly relevant for the H19 locus, as this is
measured around 30%, whereas 50% could be expected.
Table 2. Association between SGA and DNA methylation.
IGF2DMR methylation (n=499) H19 methylation (n =510)
be`ta1 95% CI P-value be`ta1 95% CI P-value
MODEL 1: adjusted for correlations between CpG sites, bisulphite
batch, gestational age
Small-for-gestational age (,22 SDS) 21.26 22.10; -0.42 0.003 20.15 20.78; 0.48 0.635
MODEL 2: model 1 + maternal age, maternal educational level,
parity and fetal gender
Small-for-gestational age (,22 SDS) 21.22 22.07; 20.37 0.005 20.25 20.90; 0.40 0.443
MODEL 3: model 2 + maternal BMI, folic acid supplement use,
smoking and the occurrence of preeclampsia
Small-for-gestational age (,22 SDS) 21.07 21.93; -0.21 0.015 20.27 20.94; 0.39 0.422
Results from linear mixed model analyses with small-for-gestational age as independent variable and DNA methylation as dependent variable.
1Analyses were performed with square-root transformed methylation data and values are presented as regression coefficients (95% confidence interval).
doi:10.1371/journal.pone.0081731.t002
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Therefore, it would be valuable to replicate our findings and to
validate the chosen methodology. However, others have investi-
gated this region and found comparable levels [12,20,31].
Therefore, we believe that our absolute DNA methylation levels
are reliable, but most importantly the estimated differences seem
to be valid.
DNA methylation was measured in umbilical cord white blood
cells and not in other tissues. Therefore, it could be argued that
DNA methylation patterns differ in various cell populations
[37,38]. There is a possibility that the differences in DNA
methylation could be attributed to the cellular heterogeneity in
leukocytes. Unfortunately, no cell count was available for our
study population. Therefore, we cannot assess to what extent this
has influenced our results. It would be interesting to address this
question in future studies. DNA methylation patterns of IGF2DMR
have been compared in blood and in buccal cells and showed a
reasonable correlation (Spearman r,0.5) [37]. It has also been
reported that IGF2DMR methylation in blood may be informative
as it marked the methylation patterns in colon tissue [39].
However, DNA methylation can still differ between tissues.
Therefore, it is important to establish in future studies correlations
between DNA methylation in peripheral tissues, such as blood,
and tissues that are directly involved in the disease. It would be
informative to address this question with DNA methylation
measurement at a genome-wide level.
Conclusions
Our analyses suggest that fetal and infant growth are associated
with DNA methylation of IGF2DMR and H19. The observations
in this paper could offer support for a potential functional link
between DNA methylation in cord blood in the investigated genes
and birth outcomes. The understanding how epigenetic control
depends on early exposure may shed light on the link between fetal
development and health over the lifespan and ultimately suggest
new ways to prevent human disease.
Supporting Information
Table S1 Details of measured amplicons and PCR
primers. 1 Genome built: GRch 37.67. 2 Forward and reverse
primer that will amplify the bisulphite converted genomic DNA.
According to the EpiTyper technology, taqs were added to the
59end of the primers. Forward primer: 10mer spacer tag is added
at the 59 primer end with the following sequence: 59-AGGAA-
GAGAG + primer. Reverse primer: T7 promoter is added to the
59 primer end with the following sequence: 59-CAGTAATAC-
GACTCACTATAGGGAGAAGGCT + primer. 3 Sequenom,
Inc, San Diego, USA
(DOC)
Table S2 Details quality control.
(DOC)
Table S3 Details of genetic variants. MAF: minor allele
frequency, HWE: Hardy-Weinberg equilibrium, * effect allele
(DOC)
Table S4 DNA methylation and newborn growth pa-
rameters, with exclusion of ADHD cases. Results from
linear mixed model analyses with DNA methylation as dependent
variable and the fetal growth parameters as independent variables.
ADHD cases were excluded for these analyses. Analyses were
performed with square-root transformed methylation data and
Table 4. Associations between SNPs in the IGF2/H19 locus and DNA methylation.
IGF2DMR methylation (n=499) H19 methylation (n =510)
Genetic variant Gene be`ta1 95% CI P-value be`ta1 95% CI P-value
rs3741205 IGF2 1.20 0,71; 1.69 2.0 E-6 20.06 20.42; 0.30 0.742
rs2067051 H19 20.44 20.86; -0.02 0.041 0.28 20.02; 0.59 0.066
rs2251375 H19 0.48 0.04; 0.93 0.033 0.06 20.26; 0.38 0.717
rs4929984 H19 20.33 20.75; 0.09 0.123 0.27 20.04; 0.57 0.084
rs1801131 MTHFR 20.03 20.45; 0.40 0.898 20.07 20.38; 0.24 0.654
rs1801133 MTHFR 0.07 20.35; 0.49 0.752 20.05 20.35; 0.25 0.750
Result from linear mixed model analyses with DNA methylation as dependent variable and the genetic variant as independent variable.
1Analyses were performed with square-root transformed methylation data and adjusted for CpG, bisulphite plate, gestational age at birth and gender.
doi:10.1371/journal.pone.0081731.t004
Table 5. Mediating effects of DNA methylation.
Small for gestational age
aOR 95% CI P-value
Model 1: adjusted for gender
rs3741205 1.41 1.24; 1.61 1.961027
Model 2: model 1 + mean DNA methylation of IGF2DMR
rs3741205 1.26 1.10; 1.44 0.001
Result from logistic regression analyses with small-for-gestational age as dependent variable and the genetic variant as independent variable. aOR: adjusted odds ratio,
95 CI and their corresponding P-value represent the effect of the minor allele (C-allele) on the risk of having a small-for-gestational age infant.
doi:10.1371/journal.pone.0081731.t005
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values are presented as regression coefficients (95% confidence
interval).
(DOC)
Table S5 DNA methylation and newborn growth pa-
rameters, with exclusion of LGA cases. Results from linear
mixed model analyses with DNA methylation as dependent
variable and the fetal growth parameters as independent variables.
LGA cases (. 2SDS) were excluded for these analyses. Analyses
were performed with square-root transformed methylation data
and values are presented as regression coefficients (95% confi-
dence interval).
(DOC)
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